Skip to content
AgingNexus
☰ Menu
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Screening for Cardiac Amyloidosis With Nuclear Cardiology for Minority Populations

Authors not listed

Mathew S. Maurer, MD · 2019

Mitochondrial dysfunction Human Randomized controlled trial
＋ Sign in to save

Abstract

In this study, the investigators recruited a cohort of elderly Black and Hispanic patients with heart failure to define the number of patients who have cardiac amyloidosis by utilizing highly sensitive heart imaging and blood tests. The investigators also explored differences in genetics and sex as they relate to heart failure disease progression in cardiac amyloidosis.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-05-31 MST

Cite this

APA
Anonymous. (2019). Screening for Cardiac Amyloidosis With Nuclear Cardiology for Minority Populations. <em>Mathew S. Maurer, MD</em>. https://clinicaltrials.gov/study/NCT03812172
Vancouver
Anonymous. Screening for Cardiac Amyloidosis With Nuclear Cardiology for Minority Populations. Mathew S. Maurer, MD. 2019.
BibTeX
@misc{anon2019Screen, title = {Screening for Cardiac Amyloidosis With Nuclear Cardiology for Minority Populations}, author = {Anonymous}, journal = {Mathew S. Maurer, MD}, year = {2019}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings